The maintenance of the enterohepatic circulation of bile acids by the liver requires the removal of bile acids from the portal blood, their transport through the hepatocyte and finally biliary excretion. Bile acid synthesis appears to be linked to this circulation, since the formation ofan external biliary fistula or the feeding of the anion-exchange resin, cholestyramine, leads to induction of cholesterol 7a-hydroxylase (Boyd et al., 1969; Shefer et al., 1970; Boyd et al., 1973) and an increase in the rate of synthesis of bile acids from cholesterol (Eriksson, 1957; Percy-Robb & Boyd, 1970) .
Although the mechanism whereby the bile acids pass through the hepatocyte and apparently affect the activity of cholesterol 7a-hydroxylase is not known, analogy with present knowledge of hepatic transport of many compounds and also of steroidinduced enzyme synthesis suggests that proteins present in liver 100000g supernatants might be involved. Thus it has been proposed that the transport of many compounds from the blood into the liver involves a group of cytoplasmic proteins, X, Y (ligandin) and Z (Levi etal., 1969; Levine etal., 1971; Litwack et al., 1971) . Further, the induction ofhepatic enzymes by steroid hormones appears to require initial binding ofthe steroid to a cytoplasmic receptor protein (Rousseau et al., 1972; Thompson & Lippmann, 1974) . Such steroid-protein complexes can apparently interact with nuclear receptors and so affect the transcriptional process (O'Malley et al., 1972; Lippmann & Thompson, 1973) . The bile acids possess the perhydrocyclopentanophenanthrene rimg structure and since over 50 % ofthe bile acids In whole Vol. 156 homogenates of rat liver are found in the 100OOg supernatant (Okishio & Nair, 1966) , bile acids might also be bound by supernatant proteins. Binding might aid the passage of bile acids through the cytoplasm, to either the bile ducts for excretion or the nucleus.
We have therefore investigated the binding of cholic acid (3a,7a,12a-trihydroxy-5,8-cholan-24-oic acid) to hepatic 1000OOg supernatants by equilibrium dialysis and gel-exclusion chromatography.
Materials and Methods Chemicals
Cholic acid (Maybridge Chemical Co., Tintagel, CornwaJl, U.K.) was recrystallized four times from methanol, and a 3.6mM solution was made up in ethanol/water (1:20, v/v) . At monthly intervals the purity of this solution was checked by placing a portion (10j) on a silica-gel 60 plate (Merck A.-G., Darmstadt, Germany) and developing in either trimnethylpentane/di-isopropyl ether/acetic acid (2:1:1, by vol.) (Hamilton & Muldrey, 1961) or in chloroform/methanol/acetic acid/water (30:10:3:2, by vol.) (Kelly & Doisy, 1964) . A single spot corresponding to cholic acid was seen after spraying the plate with anisaldehyde/acetic acid/conc. H2S04 (1:100:2, by vol.) (Kritchevsky et al., 1963) .
[24-14C]Cholic acid (51 Ci/mol)waspurchased from The Radiochemical Centre, Amersham, Bucks., U.K. A working solution (lOmCi/l) was prepared in ethanol and its purity checked by t.l.c. as described above. After development, the plate was dried at 100°C for 20min, left to cool and divided into 18 horizontal 1 cm strips, which were scraped into plastic scintillation vials for the determination of radioactivity. In all cases 99 % of the radioactivity on the plate was found in a single spot corresponding in position to cholic acid.
Proteolytic enzyme preparations were from Streptomyces griseus (Pronase; Koch-Light Laboratories, Colnbrook, Bucks., U.K.) and from Bacillus subtilis (Nagarse; Teikoku Chemical Industry Co., Osaka, Japan). Human albumin was obtained from the Protein Fractionation Centre, Scottish National Blood Transfusion Association, Edinburgh, Scotland, U.K., as a 200g/1 solution containing octanoic acid and mandelic acid. Polyethylene glycol (mol.wt. 25000) was obtained from Union Carbide, Southampton, Hants., U.K. The anion-exchange resin, cholestyramine (main constituent, polystyrene trimethylbenzyl ammonium chloride), was purchased as Cuemid from Merck, Sharp and Dohme, West Point, PA, U.S.A.
Animals
Male Wistar rats (300-330g body wt.) fed ad libitum were used. In the cholestyramine-feeding experiments animals were maintained for 4 days on a soft diet (70 % wholemeal flour, 25 % skimmed.milk powder, 5% brewer's yeast, by wt.) to which was added 4% (w/w) cholestyramine. To confirm induction of cholesterol 7ax-hydroxylase, enzyme activity was assayed by the method of Boyd et al. (1973) . Sodium phenobarbitone (25mg) in sterile water (0.5ml) was administered subcutaneously for 7 successive days and the animals were killed on day 8.
Preparation ofsupernatantfractions
Rats were anaesthetized with diethyl ether and the liver was perfused in situ via a portal-vein cannula with approx. 20ml of ice-cold phosphate/NaCl buffer containing sucrose (250mM). Phosphate/ NaCl buffer was prepared by adjusting a solution of Na2HPO4 (20mM) containing NaCl (100mM) to pH7.4 with KH2PO4 (20mM) containing NaCl (100mM). When seen to be free of blood thelivers were removed, gently dried, weighed and homogenized with 2 vol. of the same buffer in a Teflon-glass homogenizer. The homogenate was centrifuged (2500g; 4°C; 15min), the cellular debris discarded and the supernatant re-centrifuged (100000g; 4°C; 60min). The resulting supernatant fraction was harvested after removal of the lipid layer and dialysed overnight at 4°C. This initial dialysis was performed to remove components of the supernatant with mol.wt. less than about 14000 and to decrease the content ofendogenous cholic acid in the supernatant.
T.l.c. (Hamilton & Muldrey, 1961) (15-550 nmol) was injected into one half-ell and phosphate/ NaCl buffer (1 ml) was injected into the other halfcell. During dialysis, samples (104ul) were taken through ports from both sides of the membrane and the radioactivity was determined. Equilibrium was reached after 120min.
When [14C]cholic acid was dialysed against hepatic supematants (1 ml, approx. 5g of protein/l), comparison of the total amount of radioactivity used with the amounts found in the half-ells during dialysis showed that more than 98% of the radioactivity was recovered. The small loss of radioactivity was probably due to binding to the dialysis membrane. In every instance there was no significant difference between the amounts of ligand bound at 150 and 180min suggesting that equilibrium had been attained by 150min and that the binding capacity of supernatants was unchanged during the dialysis period.
In experiments to determine the nature of the binding components, portions of 100000g supernatants were incubated with proteolytic enzymes.
A supernatant was divided into three portions (3ml) and each portion was diluted with an equal volume of phosphate/NaCl buffer. One portion of diluted supernatant was used as a control solution, to the second portion was added 10mg of the enzyme preparation from Strep. griseus (Pronase) and to the third portion was added 10mg of the preparation from B. Subtilis (Nagarse). After the enzymes had been dissolved the solutions were placed in separate dialysis sacs and dialysed overnight against phosphate/NaCl buffer (40C); the protein concentration 1976 of each of the three solutions was then measured. In the control solution the protein concentration was 16g/1, in the Pronase-treated solution 1 g/l, and in the Nagarse-treated solution 2g/l. Each solution was then diluted with an equal volume of phosphate/ NaCl buffer, and portions (1 ml) were dialysed against phosphate/NaCl buffer (1 ml) containing ['4C]cholic acid (lOOnCi) and cholic acid (ISOnmol).
Dialysis of known amounts of cholic acid against dilutions of a 1000OOg supernatant showed that the amount of cholic acid bound was inversely proportional to the supernatant dilution. To check the reliability of the system, the parameters were determined for the binding of cholic acid (15-130nmol per half-cell) to human albumin (4.8-6.8 g/1). The values for the dissociation constant (71 umol of cholic acid/I) and the binding capacity (25,pmol of cholic acid/g of protein) were similar to those obtained by Burke et al. (1971) for the primary cholic acidbinding sites of human albumin.
Sephadex column chromatography
Gel-filtration experiments were performed on columns (30cmx2cm) of Sephadex G-75 equilibrated with phosphate/NaCl buffer. The columns were eluted at 4°C with the same buffer, the flow rate being 24ml/h and the fraction volume 3.5ml. The void volume, determined by using Dextran Blue, was 50ml.
The The presence of the anion-binding proteins, X, Y and Z described by Levi et al. (1969) , was demonstrated by adding bromosulphthalein (2.5mg) and portions (2ml) of supernatant to the Sephadex G-75 column and measuring the amount of bromosulphthalein in the protein-containing fractions. In some experiments the column fractions containing X protein (total volume 24.5 ml) and Y protein (total volume 28ml) were combined separately and each was dialysed against cholic acid. The protein concentration in fractions containing X protein was sufficiently high (5-6.5g/l) to allow immediate dialysis. In fractions containing Y protein, however, the protein concentration was low and the pooled fractions were first concentrated by dialysis at 1°C against polyethylene glycol (300g made up to 1500ml with water). When the volume ofthe protein-containing solution was decreased by 50% (approx. 8h) it was removed, placed in a fresh dialysis sac and dialysed overnight at 4°C against phosphate/NaCl Vol. 156 buffer. The final solution (protein concentration 4.3-5.3 g/1) was dialysed to equilibrium against cholic acid.
Analytical methods
Total protein concentrations in liver supernatants were measured by the method of Lowry as descnrbed by Herbert et al. (1971) , with bovine albumin (Armour Pharmaceutical Co., Chicago, IL, U.S.A.)
as the standard. Protein concentrations in the fractions from the Sephadex G-75 column were calculated from the extinction values at 280nm. Bromosulphthalein was measured by the extinction values at 580nm after the addition of NaOH (100l1; 1OM) to each column fraction.
At the end of experiments (1 80min), samples were regularly taken from both sides of the dialysis membrane and the integrity of both the [14C]cholic acid and the unlabelled cholic acid was confirmed by t.l.c.
Radioactive counting was performed by using a toluene-based scintillant [2,5-diphenyloxazole, 7g; 1,4-bis-(4-methyl-5-phenyloxazol-2-yl)benzene, 0.6g; naphthalene, 150g; 2-ethoxyethanol, 300ml; toluene to 1 litre]. Samples (lOpjl) of diffusate and nondiffusible material were counted with a standard deviation of less than 0.5%.
Analysis ofresults
The binding of a ligand to a protein where all the binding sites are identical and independent of each other is described by a rectangular hyperbola. The characteristic parameters of binding are K (dissociation constant) and N (mol of ligand bound/mol of protein). These parameters can be estimated by determining the amount of ligand bound per mol of protein (r) at different concentrations of free ligand (f). Values for K and N can be calculated from the linear regression of I Ir on 1 If. If, however, two proteins bind the ligand, one with a relatively high affinity (K1, Nj) and the other with a relatively low affinity (K2, N2) the binding process is described by the equation:
Nrf N2'f r-+ K1+f K2
( 1) provided that f<<K2. This equation was fitted to the experimental data by the method of least squares to give values of the constants K1,N2 and N2/K2. The non-linear equation was solved by the method of Davidenko as described by Broyden (1969) . (Table 1 ). When 1000OOg supernatants were treated with the proteolyticenzymepreparations (Pronase or Nagarse) the control solution bound the expected amount of cholic acid (Fig. 1) , whereas the solutions incubated with the proteolytic enzymes bound no cholic acid. This suggests that protein is an integral part of the cholic acid-binding component.
To determine whether more than one component in the 1000OOg supernatant was capable of binding cholic acid, two series ofexperiments were performed. First, a mixture of supernatant and [14C]cholic acid was eluted from a column of Sephadex G-75; the elution pattern (Fig. 2) shows that little radioactivity was associated with the protein-containing fractions, suggesting that any [14C]cholic acid-protein complex dissociated during passage through the column. More than 95 % of the radioactivity was recovered in the eluate. Secondly, portions of 1000OOg supernatant were eluted from columns of Sephadex G-75, and the fractions described by Levi et al. (1969) as X and Y were identified, collected and combined separately (Fig. 2) . The binding characteristics of these fractions are shown in Figs. 3(a) and 3(b) and are summarized in Table 1 . The combined X fraction only contains binding proteins with low affinities, whereas the pooled Y fraction, besides containing a protein with low affinity, also contains one with a high affinity. The whole supernatant therefore contains at least two distinct components that can bind cholic acid.
Cholestyramine-treated animals
After feeding rats for 4 days on a diet containing 11 4% (w/w) cholestyramine, microsomal cholesterol 7a-hydroxyalse activity was increased 8-10-fold. The 22 unfractionated supernatants gave a binding plot that was virtually indistinguishable from that in Fig. 1. 
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The parameters were similar to those found for the untreated animals ( (Fig. 1) shows the way in which such an equation corresponds to the experimental data; there is good agreement between this line and the experimental points. The All animals given phenobarbitone had a greater liver weight (10.2-11.6g) than similar untreated animals (7.8-9.6g), but body weight was unchanged.
The concentration-dependence of binding was similar in form to that shown for untreated animals ( Fig. 1) but differed from it in that, at any concentration, the supernatants from the phenobarbitonetreated animals bound more cholic acid per g of protein than did those from the untreated ones. The results (Table 1) 
Discussion
Our experiments show that 1000OOg supernatants prepared from rat livers contain at least two components able to bind cholic acid. Although one proVol. 156 tein was apparently not saturated by the amounts of cholic acid used, the other appeared to be tending towards saturation. Separation of supernatants into fractions containing the anion-binding proteins X and Y showed that although both fractions contained a component(s) with a low binding affinity, the Y fraction also contained a component with a higher binding affinity.
Equilibrium dialysis allows estimation of free and bound ligand concentrations without the use of adsorbents. Although buffer solutions of relatively high ionic strength and relatively low macromolecule concentration are used to overcome the Donnan effect (Hughes & Klotz, 1956) , this technique has two advantages over methods using agents such as talc or charcoal to separate free from bound ligand. First, since separation cannot be achieved instantaneously, the estimated amount of bound ligand must be less than that obtaining at equilibrium. Secondly, if the amount of free ligand is calculated from the difference between the amount of ligand bound and the total amount ofligand used, the results will be susceptible to the sort of systematic error and misinterpretation described by Swillens & Dumont (1975) .
The proteins present in liver 100000g supernatants able to bind cholic acid were further studied by eluting supernatants from columns of Sephadex G-75 and separately collecting the X and Y fractions. Although X protein has been reported to bind anions nonspecifically (Levi et al., 1969) , Y protein or ligandin (Litwack et al., 1971) , a protein with a molecular weight of approx. 40000, may be involved in the hepatic removal of anions such as bromosulphthalein from plasma (Levine et al., 1971) . Studying binding of cholic acid by these fractions can be criticized since the mechanism of bromosulphthalein excretion from hepatocyte into the bile duct appears to be different from that of bile acids (Heaton, 1972) . Further, Levi et al., (1969) To investigate a physiological role for the hepatic binding of cholic acid, rats were treated with cholestyramine or phenobarbitone. The first of these agents sequesters bile salts in the intestine, thus increasing the faecal excretion of acidic steroids (Grundy et al., 1971) . There is also induction of cholesterol 7a-hydroxylase, the rate-limiting enzyme in bile acid synthesis (Boyd etal., 1973) . If, as has been suggested, bile salts have a feedback inhibition effect on their own synthesis, analogy with other steroids suggests that normally interaction between nuclear receptors and steroid molecules bound to cytoplasmic proteins represses synthesis of cholesterol 7a-hydroxylase. Induction of the enzyme by the feeding of cholestyramine to animals might alter the amount of cytoplasmic protein available for binding, thus producing a change in the binding characteristics of supernatants for cholic acid. The cholic acid-binding capacity of these supernatants, however, was similar to that of supernatants prepared from untreated animals. The second agent used, phenobarbitone, has a number of effects on bile acid metabolism and has been used to treat patients with intrahepatic cholestasis (Stiehl et al., 1972) . Phenobarbitone can affect the activity of cholesterol 7a-hydroxylase, although this effect appears to be species-dependent (Shefer et al., 1972) . It seemed important to study the effects of phenobarbitone on cholic acid binding to the partially saturated protein in Y fractions since Reyes et al. (1971) have shown that administration of phenobarbitone to rats results in an increase in the concentration of Y protein and a simultaneous increase in the clearance of bromosulphthalein. In our experiments rats were given amounts of phenobarbitone similar to those administered by Reyes et al. (1971) . The liver weights of our animals were significantly higher than those of untreated animals, but we were unable to show an increase in the bromosulphthalein-binding capacity of these supernatants. There was, however, an increase in the cholic acid-binding capacity of these supernatants, occurring only in the low-affinity component.
The physiological role of the cholic acid-binding proteins is unknown. They may be involved in the transport of cholic acid to the bile duct, in the regulation, at the nuclear level, of bile acid synthesis or in the storage of the bile acids within the liver. In this context the magnitude of the dissociation constants may be important. Presumably a component that 1976 binds a ligand with a high affinity constant is an inefficient vehicle for transport, because the ligand (once bound) is unlikely to dissociate, whereas tight binding would be an expected property if the complex were to be active in the nucleus. If so, the magnitude of the dissociation constants for the binding of cholic acid to supernatant components are more in keeping with the first of these possibilities for they are approximately of the same order of magnitude as the concentrations of cholic acid in portal blood (Okishio & Nair, 1966; Cronholm & Sj6vall, 1967) . They are several orders of magnitude greater than the dissociation constants (2 x10-10M) reported by Higgins et al. (1973) for the association ofthe receptor protein-dexamethasone complex from hepatoma cells to isolated nuclei or for the dissociation constants of several steroids thought to affect the transcription process, and hepatoma-cell cytosol proteins . The concept that the liver has a storage capacity for anions such as bromosulphthalein was introduced by Wheeler et al. (1960) . Storage of bile acids is suggested by the demonstration that the maximum capacity for taurocholate uptake from plasma is considerably in excess of the maximum rate of secretion into bile (Glasinovic et al., 1975) . It is possible that this storage function involves bile acid-binding proteins similar to those described for cholic acid, particularly since treatment with phenobarbitone increases the size of the bile acid pool (Mok et al., 1974) and the binding capacity of 1000OOg supernatants.
